Veranex Executive and Leadership Team

July, 2026

Leadership Overview

Veranex has 5 executives leading key functions including strategy, operations, finance, market access, and administration.

Driven by innovation, Veranex provides comprehensive, tech-enabled services for the medical technology industry, accelerating speed to market and unifying the entire development process.

Leadership Roles at Veranex

  • Chief Executive Officer - Megan Osorio
  • Chief Financial Officer - Sylvain Duval
  • Chief Operating Officer - David Dockhorn
  • President - Michel Bourdoncle
  • Chief Administrative Officer (CAO) - Douglas Dockhorn
  • Megan Osorio - Chief Executive Officer

    Megan Osorio, the Chief Executive Officer at Veranex, directs the overarching strategy and vision for the company's comprehensive services within the medical technology sector. Overseeing global operations, Megan Osorio ensures Veranex consistently delivers expert guidance that accelerates speed to market for its clients. This leadership role involves driving development cost control and mitigating project risks across engineering, regulatory, clinical, and market access pillars. By unifying the entire concept-to-commercialization process, Megan Osorio enables customers to realize significant efficiencies in both cost and time. The Chief Executive Officer's focus remains on enhancing market viability assessment and solidifying Veranex's position as the premier tech-enabled service provider.
    Megan Osorio

    Sylvain Duval - Chief Financial Officer

    Sylvain Duval, the Chief Financial Officer at Veranex, manages the financial strategy and fiscal health of the global, tech-enabled service provider for the medical technology industry. Overseeing all financial operations, Sylvain Duval ensures controlled development costs and optimizes investment across the company's four concept-to-commercialization pillars. This critical role involves rigorous financial planning, analysis, and reporting to support accelerated speed to market and development risk mitigation for clients. By maintaining robust financial discipline, the Chief Financial Officer directly contributes to Veranex's ability to unify the entire development process and enhance market viability assessment. Sylvain Duval's expertise underpins the company's commitment to delivering cost and time efficiencies.

    David Dockhorn - Chief Operating Officer

    David Dockhorn, the Chief Operating Officer at Veranex, executes the operational framework that supports the company's global tech-enabled services for the medical technology industry. Overseeing the day-to-day functions, David Dockhorn ensures seamless integration across engineering, design, regulatory, clinical, and market access departments. This role involves optimizing internal processes to enhance client efficiency and reduce development costs. By managing resource allocation and operational workflows, the Chief Operating Officer drives the controlled development and risk mitigation strategies central to Veranex's mission. David Dockhorn's leadership ensures that the comprehensive solutions provided consistently unify the entire development lifecycle, delivering accelerated market viability.

    Michel Bourdoncle - President

    Michel Bourdoncle, the President at Veranex, drives the strategic expansion and market positioning of the company's comprehensive, tech-enabled services for the medical technology sector. Overseeing key growth initiatives, Michel Bourdoncle ensures Veranex's global reach effectively supports accelerated speed to market and controlled development costs for clients. This leadership position involves fostering strong client relationships and identifying new opportunities within the engineering, regulatory, clinical, and market access domains. By championing the unification of the entire development process, the President enhances Veranex's reputation for development risk mitigation and accelerated market viability assessment. Michel Bourdoncle's vision guides the company's commitment to delivering unparalleled efficiencies.

    Douglas Dockhorn - Chief Administrative Officer (CAO)

    Douglas Dockhorn, the Chief Administrative Officer (CAO) at Veranex, oversees the essential administrative functions that support the company's global, tech-enabled services for the medical technology industry. Managing internal operations and corporate governance, Douglas Dockhorn ensures efficient resource utilization and compliance across all departments. This role is pivotal in facilitating controlled development costs and development risk mitigation by streamlining administrative processes that impact engineering, regulatory, clinical, and market access activities. By optimizing the internal infrastructure, the Chief Administrative Officer (CAO) contributes directly to Veranex's ability to unify the entire development process and deliver accelerated market viability. Douglas Dockhorn's oversight guarantees operational stability and supports accelerated speed to market.
    Douglas Dockhorn

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Veranex Top Executives and Leadership Team

    Who leads Veranex?
    Veranex is led by Megan Osorio (Chief Executive Officer), along with executives such as Sylvain Duval (Chief Financial Officer) and David Dockhorn (Chief Operating Officer).
    Who is part of Veranex’s executive team?
    The executive team of Veranex includes leaders such as Megan Osorio (Chief Executive Officer), Sylvain Duval (Chief Financial Officer), David Dockhorn (Chief Operating Officer) and other senior executives.
    How many executives does Veranex have?
    Veranex has 5 executives leading key business areas.
    What roles are included in Veranex’s leadership team?
    The leadership team of Veranex includes roles such as Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President, Chief Administrative Officer (CAO).